Van Echo D - Search Results

1

Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug.

Edelman MJ, Bauer K, Khanwani S, Tait N, Trepel J, Karp J, Nemieboka N, Chung EJ, Van Echo D. Edelman MJ, et al. Among authors: van echo d. Cancer Chemother Pharmacol. 2003 May;51(5):439-44. doi: 10.1007/s00280-003-0580-5. Epub 2003 Mar 12. Cancer Chemother Pharmacol. 2003. PMID: 12736763 Clinical Trial.

2

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, Egorin MJ, Sridhara R, Finley R, Hemady R, Wu S, Tait NS, Van Echo DA. Conley BA, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 1997;39(4):291-9. doi: 10.1007/s002800050575. Cancer Chemother Pharmacol. 1997. PMID: 9025769 Clinical Trial.

3

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.

Conley BA, Egorin MJ, Tait N, Rosen DM, Sausville EA, Dover G, Fram RJ, Van Echo DA. Conley BA, et al. Among authors: van echo da. Clin Cancer Res. 1998 Mar;4(3):629-34. Clin Cancer Res. 1998. PMID: 9533530 Clinical Trial.

4

Phase I study of docetaxel and topotecan in patients with solid tumors.

Tkaczuk KH, Zamboni WC, Tait NS, Meisenberg BR, Doyle LA, Edelman MJ, Hausner PF, Egorin MJ, Van Echo DA. Tkaczuk KH, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 2000;46(6):442-8. doi: 10.1007/s002800000180. Cancer Chemother Pharmacol. 2000. PMID: 11138457 Clinical Trial.

5

Phase II trial of N-methylformamide in advanced renal cancer.

Abrams JS, Tait N, Silva H, Eisenberger M, Van Echo DA, Olver IN, Aisner J. Abrams JS, et al. Among authors: van echo da. Am J Clin Oncol. 1989 Feb;12(1):41-2. doi: 10.1097/00000421-198902000-00009. Am J Clin Oncol. 1989. PMID: 2912020

6

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer.

Chiappori A, Williams C, Northfelt DW, Adams JW, Malik S, Edelman MJ, Rosen P, Van Echo DA, Berger MS, Haura EB. Chiappori A, et al. Among authors: van echo da. J Thorac Oncol. 2014 Jan;9(1):121-5. doi: 10.1097/JTO.0000000000000027. J Thorac Oncol. 2014. PMID: 24346101 Free PMC article. Clinical Trial.

7

The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method.

Tkaczuk KH, Goloubeva O, Tait NS, Feldman F, Tan M, Lum ZP, Lesko SA, Van Echo DA, Ts'o PO. Tkaczuk KH, et al. Breast Cancer Res Treat. 2008 Sep;111(2):355-64. doi: 10.1007/s10549-007-9771-9. Epub 2007 Dec 7. Breast Cancer Res Treat. 2008. PMID: 18064568

8

Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients.

Tkaczuk KH, Tait NS, Ioffe O, Tan M, Goloubeva OG, Lesko SA, Deamond SF, Zhou D, Lum ZP, Sutula MJ, Van Echo D, Ts'o PO. Tkaczuk KH, et al. Among authors: van echo d. Discov Med. 2011 Jul;12(62):33-40. Discov Med. 2011. PMID: 21794207 Free article.

9

Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia.

Lee EJ, Egorin MJ, Van Echo DA, Cohen AE, Tait N, Schiffer CA. Lee EJ, et al. Among authors: van echo da. J Natl Cancer Inst. 1988 Mar 16;80(2):131-5. doi: 10.1093/jnci/80.2.131. J Natl Cancer Inst. 1988. PMID: 3278122

10

Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin.

Conley BA, Egorin MJ, Whitacre MY, Carter DC, Zuhowski EG, Van Echo DA. Conley BA, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 1993;33(2):107-12. doi: 10.1007/BF00685327. Cancer Chemother Pharmacol. 1993. PMID: 8261569 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters